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INTRODUCTION  
Recent mouse models in stroke have shown that localized 1H MRS capable of studying evolution of 
numerous brain metabolites after transient cerebral ischemia (1) and consequently identifying early 
predictive markers for lesion (2,3). Glutamine and the sum of NAA, Tau and Glu could be applied to 
identify different degrees of transient ischemic damage as early as 3hr after insults (2,3). We thought 
longitudinal 1H MRS studying permanent stroke would help understanding its cascading damages in 
brain tissue and thus could help classifying stroke types, from transient ischemic attack with no lesion 
(TIA), minor stroke, moderate stroke and severe stroke without reperfusion. Therefore, the aim of this 
study was to study the evolution of brain metabolites after permanent focal ischemia in mice using 1H 
MRS at 14.1T and identifying possible biomarkers. 
METHODS  
All animal studies were approved by the local 
veterinary authority. Adult male ICR-CD1 
mice (n=25) underwent focal ischemia as 
previously described except removing inserted 
filaments. To minimize the effect of 
isoflurane on animals, MR studies were 
randomly performed at 30-45min, 3hr, 8hr 
and 24hr after permanent focal ischemia to 
reach 6-10 mice per time-point. At 14.1T, 
immediately after T2-weighted (T2WI) images 
(TEeff/TR=50/5000ms) were acquired and 
field homogeneities were improved (water 
linewidths <25Hz), localized 1H MRS was 
applied on ipsilateral striatum (~5.6μL) using 
SPECIAL (TE/TR=2.8/4000ms, NT=240-320, 
SNRs>10, 1 and references therein). The 
water signals with no water suppression 
(NT=8) were acquired for further absolute 
quantification. MR spectra were processed and quantified using LCModel (1 and references 
therein). The water content was assumed 80% absolute quantification. Brain metabolites were found detectable with CRLB <50%. Sham operated, 
TIA and minor stroke were taken from previous studies (2,3) and moderate 
stroke was from lei et al. 2009 (1). 
RESULTS AND DISCUSSION  
T2WI images presented sufficient anatomical structures allowing localization 
of the ipsilateral striatum (Figure 1). The T2WI images showed slightly 
abnormal T2-hyperintensities 3hr after permanent stroke while ADC maps in 
the ipsilateral striatum and cortex were consistently lower than those in the 
contralaterial side (data not shown). Noticeably, MR spectra at 3hr presented 
highly increased GABA and decreased glutamine, which were different from 
those of transient ischemic attacks, i.e. elevated glutamine (Figure 1). When 
plotting glutamine contents against NAA+Glu+Tau (mostly locating in 
neurons) obtained at 3hr after operation, data from permanent stroke were 
clearly separated from four other groups, sham operated, TIA, minor and 
moderate stroke (Figure 2). In addition, we notice that GABA elevated 
immediately after permanent stroke, i.e. shortly after operation (Figure 3). This 
is consistent with previous studies (4 and references therein). Therefore, we 
could identify different stroke types based on metabolites measured by means 
of 1H MRS. It is interesting to note that the degradations of selected 
metabolites, such as NAA and Tau, were close to a mono-exponential decay 
(R2>0.9) except a bi-exponential evolution in GABA (Figure 3). This could be 
explained by different mechanisms for these metabolites evolving after 
permanent stroke. On top of that, the progressive decay could possibly help 
identifying stroke onset time, a major issue in a large fraction of patients with unknown stroke onset time. In conclusion, studying metabolites using 
1H MRS allowed differentiating various stroke subtypes and thus could improve diagnosis and treatment selection in clinics. 
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 Figure 2. Scatter plot of glutamine over sum of NAA, 
Tau and Glu measured at 3hr after operation. ‘*’ 
indicates data were from previous studies, (2,3) and 
‘†’ from Lei et al. 2009 (1). 
 Figure 1 Typical localized 1H MR spectra 
of mouse striatum (square in T2WI image) 
3hr after sham, minor stroke and permanent 
stroke at 14.1T. ‘*’ indicates data were from 
previous studies, (2,3). Noticeable 
differences in Glu, Gln and GABA between 
three groups were highlighted in grey shaded 
areas. 
Figure 3 Evolution of selected metabolites after permanent occlusion. 
The curved lines were the fitting results for the degradations of Tau, 
NAA and Glu+Tau+NAA, i.e. mono-exponential decay. Alternatively 
GABA was fitted bi-exponentially. Error bars are SEMs.  
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